Japan Medical Dynamic Marketing, Inc.

As of March 31, 2026, Japan Medical Dynamic Marketing, Inc. carries a market capitalization of 14.15B, placing it among publicly traded companies globally. Its enterprise value stands at 16.94B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Japan Medical Dynamic Marketing, Inc.'s next confirmed earnings release is scheduled for November 4, 2026.

As of March 31, 2026, Japan Medical Dynamic Marketing, Inc. has 26.35M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Japan Medical Dynamic Marketing, Inc. maintains a current ratio of 3.23, meaning it holds 3.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, Japan Medical Dynamic Marketing, Inc.'s stock has gained approximately 16.54% over the past 52 weeks. The 50-day moving average sits at 705.56, while the 200-day moving average is 674.79.

As of March 31, 2026, Japan Medical Dynamic Marketing, Inc. holds 3.11B in cash and equivalents against 5.87B in total debt, resulting in a net debt position of 2.54B. Total book value stands at 25.40B, with working capital of 17.18B providing operational flexibility.

Japan Medical Dynamic Marketing, Inc.'s most recent stock split took place on May 28, 2002 with a 10:11 split ratio.